Kazuki Kakimoto

9PUBLICATIONS
8CO-AUTHORS
AutoimmunityPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 23, 2026
Behçet-like Gastrointestinal Lesions and IgA Vasculitis Associated With Trisomy 8-Negative Myelodysplastic Syndrome.

|Oct 27, 2025
A Clinical Prediction Model for Early Colectomy in Patients With Severe Ulcerative Colitis Treated With Tacrolimus.

Hikaru Shimizu, Kazuki Kakimoto, Mai Utsumi

|May 19, 2025
Ulcerative Lesion of the Ileocecal Region in a Patient With Immunodeficiency.

Naohiko Kinoshita, Kazuki Kakimoto, Emiri Kaji

|Aug 29, 2024
C-reactive protein-to-lymphocyte ratio is a novel biomarker for predicting the long-term efficacy of ustekinumab treatment in ulcerative colitis.

Ryoji Koshiba, Kazuki Kakimoto, Noboru Mizuta

|Jul 13, 2024
Correction: Tatsumi et al. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. J. Clin. Med. 2023, 12, 7165.

Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara

|Nov 25, 2023
Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.

Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara

Pageof 2

Frequent Collaborators

7 joint publications

Ryoji Koshiba

4 joint publications

Yuki Hirata

3 joint publications

Kazuhiro Ota

2 joint publications

Hiroaki Ito